Latest debt-to-equity ratio
Gyre Therapeutics Debt-to-equity ratio
Direct answer
Gyre Therapeutics's debt-to-equity ratio is 2.07%.
The verified market snapshot reports 2.07%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 26, 2026.
Get free Gyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.07%
Explore related company data
View Gyre Therapeutics's market capitalizationView Gyre Therapeutics's price-to-book ratioView Gyre Therapeutics's return on equityView Gyre Therapeutics's dividend yieldView Gyre Therapeutics's 52-week price rangeView Gyre Therapeutics's revenue growthView Gyre Therapeutics's profit marginView all Gyre Therapeutics key metricsReturn to Gyre Therapeutics profile